Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bicycle Therapeutics (BCYC) Deferred Taxes: 2020-2024

Historic Deferred Taxes for Bicycle Therapeutics (BCYC) over the last 5 years, with Dec 2024 value amounting to -$5.2 million.

  • Bicycle Therapeutics' Deferred Taxes rose 98.61% to -$46,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.7 million, marking a year-over-year increase of 39.05%. This contributed to the annual value of -$5.2 million for FY2024, which is 258.08% down from last year.
  • Per Bicycle Therapeutics' latest filing, its Deferred Taxes stood at -$5.2 million for FY2024, which was down 258.08% from $3.3 million recorded in FY2023.
  • In the past 5 years, Bicycle Therapeutics' Deferred Taxes registered a high of $3.3 million during FY2023, and its lowest value of -$5.2 million during FY2024.
  • Its 3-year average for Deferred Taxes is -$2.3 million, with a median of -$5.0 million in 2022.
  • In the last 5 years, Bicycle Therapeutics' Deferred Taxes soared by 166.44% in 2023 and then slumped by 258.08% in 2024.
  • Bicycle Therapeutics' Deferred Taxes (Yearly) stood at -$673,000 in 2020, then slumped by 147.85% to -$1.7 million in 2021, then plummeted by 198.32% to -$5.0 million in 2022, then spiked by 166.44% to $3.3 million in 2023, then slumped by 258.08% to -$5.2 million in 2024.